Ignite Creation Date:
2024-05-05 @ 5:02 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00371982
Status:
TERMINATED
Last Update Posted:
2006-09-04
First Post:
2006-09-01
Brief Title:
Effect of Fish Oil on Adiposity and Atherogenic Factors in Type 2 Diabetic Women
Sponsor:
Assistance Publique - Hôpitaux de Paris
Organization:
Assistance Publique - Hôpitaux de Paris
Study Overview
Official Title:
None
Status:
TERMINATED
Status Verified Date:
2002-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
1 whether the intake of n-3 PUFA has additional effects on insulin sensitivity and adiposity total fat mass and adipocyte morphology and function in T2D women
2 n-3 PUFA supplementation might influence inflammatory genes expression in the adipose tissue of T2D patients
2 n-3 PUFA supplementation might influence inflammatory genes expression in the adipose tissue of T2D patients
Detailed Description:
Thus the present study was designed to evaluate the effects of n-3 PUFAs dietary supplementation on lipid and glucose homeostasis and to address the impact of this treatment on adiposity and adipose tissue gene expression in T2D womenA total of 27 T2D women BMI 27-35kgm² age 40-60 y were randomly allocated to two months of 3 gday of either fish oil 18 g n-3 PUFA or placebo paraffin oil in a double-blind parallel design
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None